Radiofrequency thermal ablation of renal graft neoplasms: A literature review

Roberto Iezzi, Jacopo Romagnoli, Franco Citterio, Riccardo Manfredi, Francesca Carchesio, Maria Paola Salerno, Alessandro Posa

Research output: Contribution to journalArticle

1 Citation (Scopus)


Neoplasms occurring in renal grafts represent a relatively novel and rare condition, whose treatment has not been standardized yet. Radiofrequency thermal ablation (RFA) of renal graft neoplasms is a nephron-sparing treatment, reported to be safe and effective. However, even in the RFA field, there is no procedural standardization. In this review of the literature, mostly composed by case reports and case series, we aim to assess efficacy and complication rates of RFA in the treatment of kidney graft neoplasms, and summarize the various procedural protocols found in the literature, using an easy-to-read point format. We performed a literature search in PubMed/MEDLINE with an overall description of 66 renal graft lesion treated with RFA, with a mean follow-up of 16.3 months (range 3–54.3). Technical success was achieved in all cases, with only one recurrence reported (1/66; 1.5%), occurring at 6-months follow-up. Complications occurred in 11 (11/66; 16.7%) patients. Based on literature review, RFA of renal graft neoplasms seems to be a feasible, safe, and effective treatment.
Original languageEnglish
Pages (from-to)161-165
JournalTransplantation Reviews
Publication statusPublished - 2019


  • Ablation
  • Kidney
  • Personalized medicine
  • Precision medicine
  • Radiofrequency
  • Transplant


Dive into the research topics of 'Radiofrequency thermal ablation of renal graft neoplasms: A literature review'. Together they form a unique fingerprint.

Cite this